Spyre Therapeutics, Inc 10-K for FY2022
Spyre Therapeutics, Inc. (SYRE)
10-K
2023-03-02
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
Spyre Therapeutics, Inc filed this 10-K on March 2, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.33M
- down 87.6% from $18.74M a year earlier
- Net loss
- $83.82M
- compared with a net loss of $65.8M a year earlier
- Diluted EPS
- -$0.99
- compared with -$1.00 a year earlier